Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mayers

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
The Laryngoscope|February 24, 2001
Autologous fibrin sealant reduces pain after tonsillectomyC W Gross, R Gallagher, R J Schlosser, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study GroupD L Mayers, A J Japour, J M Arduino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infectionT E Hickey, P J Blair, S Perfetto, et al.
Controlled Clinical Trials|April 18, 2001
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupA J Japour, D L Mayers, V A Johnson, et al.
Virology|June 20, 1995
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptaseR W Buckheit, V Fliakas-Boltz, S Yeagy-Bargo, et al.
AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strainsD L Mayers, J A Mikovits, B Joshi, et al.
Cytometry|February 15, 1997
Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individualsS P Perfetto, T E Hickey, P J Blair, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Laryngoscope|February 24, 2001
Autologous fibrin sealant reduces pain after tonsillectomyC W Gross, R Gallagher, R J Schlosser, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study GroupD L Mayers, A J Japour, J M Arduino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infectionT E Hickey, P J Blair, S Perfetto, et al.
Controlled Clinical Trials|April 18, 2001
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupA J Japour, D L Mayers, V A Johnson, et al.
Virology|June 20, 1995
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptaseR W Buckheit, V Fliakas-Boltz, S Yeagy-Bargo, et al.
AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strainsD L Mayers, J A Mikovits, B Joshi, et al.
Cytometry|February 15, 1997
Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individualsS P Perfetto, T E Hickey, P J Blair, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
Pageof 10